Tri medyne Revenue and Competitors
Estimated Revenue & Valuation
- Tri medyne's estimated annual revenue is currently $2.9M per year.
- Tri medyne's estimated revenue per employee is $125,500
Employee Data
- Tri medyne has 23 Employees.
- Tri medyne grew their employee count by 0% last year.
Tri medyne's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Principal Financial Officer | Reveal Email/Phone |
2 | President | Reveal Email/Phone |
Tri medyne Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3560M | 9803 | 2% | $19.2M | $19.1B |
What Is Tri medyne?
Trimedyne, Inc. is a manufacturer of lasers and disposable fiber optic delivery devices for use in a variety of surgical applications including, urology, orthopedics, ENT surgery, gynecology, GI surgery, and general surgery. Trimedyne's lasers and proprietary delivery systems are designed to reduce the bleeding and trauma of conventional surgery, reduce or eliminate hospital bed stays and shorten recuperation time. Cardiodyne, a 90% subsidiary of Trimedyne is developing a heart revascularization laser system for cardiovascular surgeons and cardiologists to treat coronary artery disease, the largest single killer among medical conditions and diseases.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$2.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tri medyne News
... in three and scored two runs on two hits, including a triple. ... Bennett Medyn scored what would count as the game-winning goal on a...
... Dornier MedTech, Biolitec, Cynosure, Lynton Lasers, Novartis AG, PhotoMedex, Spectranetics, Syneron Medical, Topcon, Trimedyne.
The Tomcats conclude the season in an AMCC tri-match at Mount Aloysius ... Dylan Waskiewicz and Bennett Medyn led Thiel with 2 goals apiece.
Other Companies in Irvine
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.4M | 23 | -44% | N/A |
#2 | $2.3M | 23 | N/A | N/A |
#3 | $2.3M | 23 | N/A | N/A |
#4 | N/A | 23 | N/A | N/A |
#5 | $2.9M | 23 | -8% | N/A |